{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:49:19Z","timestamp":1782496159358,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005317","name":"Kermanshah University of Medical Sciences","doi-asserted-by":"publisher","award":["4020407"],"award-info":[{"award-number":["4020407"]}],"id":[{"id":"10.13039\/501100005317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005317","name":"Kermanshah University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.KUMS.AEC.1402.021"],"award-info":[{"award-number":["IR.KUMS.AEC.1402.021"]}],"id":[{"id":"10.13039\/501100005317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ejps.2023.106631","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T04:39:31Z","timestamp":1699591171000},"page":"106631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Preparation of polycaprolactone and polymethacrylate nanofibers for controlled ocular delivery of ketorolac tromethamine: Pharmacokinetic study in Rabbit's Eye"],"prefix":"10.1016","volume":"192","author":[{"given":"Shiva","family":"Taghe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4079-5771","authenticated-orcid":false,"given":"Shahla","family":"Mirzaeei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masood","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejps.2023.106631_bib0001","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3390\/polym15061355","article-title":"Development and characterization of drug loaded PVA\/PCL fibres for wound dressing applications","volume":"15","author":"Afzal","year":"2023","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ejps.2023.106631_bib0002","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1208\/s12248-008-9024-9","article-title":"Topical ocular delivery of NSAIDs","volume":"10","author":"Ahuja","year":"2008","journal-title":"AAPS J."},{"issue":"2","key":"10.1016\/j.ejps.2023.106631_bib0003","first-page":"153","article-title":"Preparation and evaluation of PCL-PEG-PCL micelles as potential nanocarriers for ocular delivery of dexamethasone","volume":"21","author":"Alami-Milani","year":"2018","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"09","key":"10.1016\/j.ejps.2023.106631_bib0004","doi-asserted-by":"crossref","first-page":"204","DOI":"10.7324\/JAPS.2016.60930","article-title":"Fabrication and evaluation of ketorolac loaded cubosome for ocular drug delivery","volume":"6","author":"Ali","year":"2016","journal-title":"J. Appl. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.ejps.2023.106631_bib0005","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.jcrs.2012.04.034","article-title":"Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification","volume":"38","author":"Almeida","year":"2012","journal-title":"Cataract. Refract. Surg."},{"key":"10.1016\/j.ejps.2023.106631_bib0006","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.2147\/OPTH.S15146","article-title":"Ocular pharmacokinetics of 0.45% ketorolac tromethamine","volume":"4","author":"Attar","year":"2010","journal-title":"Clin. Ophthalmol."},{"issue":"1","key":"10.1016\/j.ejps.2023.106631_bib0007","doi-asserted-by":"crossref","first-page":"93","DOI":"10.18502\/jovr.v16i1.8255","article-title":"Pattern of uveitis in Iran: a systematic review","volume":"16","author":"Bagheri","year":"2021","journal-title":"J. Ophthalmic Vis. Res."},{"issue":"10","key":"10.1016\/j.ejps.2023.106631_bib0008","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1136\/bjo.2009.157297","article-title":"Efficacy and pharmacokinetics of intravitreal non-steroidal anti-inflammatory drugs for intraocular inflammation","volume":"93","author":"Bara\u00f1ano","year":"2009","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.ejps.2023.106631_bib0009","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1586\/17469899.3.3.325","article-title":"When nanotechnology meets the ocular surface","volume":"3","author":"Bucolo","year":"2008","journal-title":"Expert Rev. Ophthalmol."},{"key":"10.1016\/j.ejps.2023.106631_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2021.106578","article-title":"Nonsteroidal anti-inflammatory drugs for retinal neurodegenerative diseases","volume":"156","author":"Chen","year":"2021","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"3","key":"10.1016\/j.ejps.2023.106631_bib0011","doi-asserted-by":"crossref","first-page":"173","DOI":"10.17925\/EOR.2012.06.03.173","article-title":"Current use of non-steroidal anti-inflammatory drugs in the treatment of ocular inflammation related to cataract surgery","volume":"6","author":"Donnenfeld","year":"2012","journal-title":"Eur. Ophthal. Rev."},{"issue":"1","key":"10.1016\/j.ejps.2023.106631_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2015.07.001","article-title":"The ocular immunology and uveitis foundation preferred practice patterns of uveitis management","volume":"61","author":"Foster","year":"2016","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ejps.2023.106631_bib0013","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejps.2013.11.016","article-title":"Development and characterization of nano-fiber patch for the treatment of glaucoma","volume":"53","author":"Gagandeep","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106631_bib0014","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejps.2013.11.016","article-title":"Development and characterization of nano-fiber patch for the treatment of glaucoma","volume":"53","author":"Gagandeep","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106631_bib0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejps.2013.11.016","article-title":"Development and characterization of nano-fiber patch for the treatment of glaucoma","volume":"53","author":"Garg","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejps.2023.106631_bib0016","doi-asserted-by":"crossref","first-page":"19","DOI":"10.51329\/mehdiophthal1441","article-title":"Optical coherence tomography angiography in intermediate uveitis-related cystoid macular edema","volume":"11","author":"Ghavidel","year":"2022","journal-title":"Med. Hypothesis Discov. Innov. Ophthalmol."},{"issue":"1","key":"10.1016\/j.ejps.2023.106631_bib0017","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/j.jcrs.0000000000000477","article-title":"Choroidal thickness after phacoemulsification: nonrandomized comparison of postoperative topical ketorolac vs dexamethasone vs combination of ketorolac\u2013dexamethasone eyedrops","volume":"47","author":"Ghiasian","year":"2021","journal-title":"J. Cataract Refract. Surg."},{"issue":"11","key":"10.1016\/j.ejps.2023.106631_bib0018","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3109\/02713680903261405","article-title":"Cyclosporine a-loaded solid lipid nanoparticles: ocular tolerance and in vivo drug release in rabbit eyes","volume":"34","author":"G\u00f6k\u00e7e","year":"2009","journal-title":"Curr. Eye Res."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2023.106631_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(00)00508-1","article-title":"Ketorolac entrapped in polymeric micelles: preparation, characterisation and ocular anti-inflammatory studies","volume":"209","author":"Gupta","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106631_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119397","article-title":"A nanofiber-based drug depot with high drug loading for sustained release","volume":"583","author":"Hou","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejps.2023.106631_bib0021","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1872211308666140130093301","article-title":"Drug delivery to the back of the eye following topical administration: an update on research and patenting activity. Recent Pat","volume":"8","author":"HS Boddu","year":"2014","journal-title":"Drug Deliv. Formul."},{"issue":"15","key":"10.1016\/j.ejps.2023.106631_bib0022","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0266-3538(03)00178-7","article-title":"A review on polymer nanofibers by electrospinning and their applications in nanocomposites","volume":"63","author":"Huang","year":"2003","journal-title":"Compos. Sci. Technol."},{"issue":"8","key":"10.1016\/j.ejps.2023.106631_bib0023","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3390\/pharmaceutics13081228","article-title":"Electrospun nanofibers of polycaprolactone\/collagen as a sustained-release drug delivery system for artemisinin","volume":"13","author":"Huo","year":"2021","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.ejps.2023.106631_bib0024","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4103\/2230-973X.143131","article-title":"Design, formulation, and evaluation of novel sustain release bioadhesive in-situ gelling ocular inserts of ketorolac tromethamine","volume":"4","author":"Jethava","year":"2014","journal-title":"Int. J. Pharm. Investig."},{"issue":"5","key":"10.1016\/j.ejps.2023.106631_bib0025","doi-asserted-by":"crossref","first-page":"e96481","DOI":"10.1371\/journal.pone.0096481","article-title":"Pharmacokinetics and efficacy of topically applied nonsteroidal anti-inflammatory drugs in retinochoroidal tissues in rabbits","volume":"9","author":"Kida","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejps.2023.106631_bib0026","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/10717544.2014.903535","article-title":"Thermosensitive PEG\u2013PCL\u2013PEG (PECE) hydrogel as an in situ gelling system for ocular drug delivery of diclofenac sodium","volume":"23","author":"Luo","year":"2016","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.ejps.2023.106631_bib0027","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/10837450.2021.2018609","article-title":"Preparation and functional evaluation of electrospun polymeric nanofibers as a new system for sustained topical ocular delivery of itraconazole","volume":"27","author":"Mehrandish","year":"2022","journal-title":"Pharm. Dev. Technol."},{"issue":"5","key":"10.1016\/j.ejps.2023.106631_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-021-02051-5","article-title":"Polyvinyl alcohol\/chitosan single-layered and polyvinyl alcohol\/chitosan\/eudragit rl100 multi-layered electrospun nanofibers as an ocular matrix for the controlled release of ofloxacin: an in vitro and in vivo evaluation","volume":"22","author":"Mirzaeei","year":"2021","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.ejps.2023.106631_bib0029","doi-asserted-by":"crossref","first-page":"593","DOI":"10.15171\/apb.2019.068","article-title":"Preparation and evaluation of Eudragit\u00ae L100 nanoparticles loaded impregnated with KT tromethamine loaded PVA-HEC insertions for ophthalmic drug delivery","volume":"9","author":"Mohammadi","year":"2019","journal-title":"Adv. Pharm. Bull."},{"issue":"15","key":"10.1016\/j.ejps.2023.106631_bib0030","doi-asserted-by":"crossref","first-page":"12483","DOI":"10.1021\/la100748g","article-title":"Coaxially electrospun PVDF\u2212 teflon AF and teflon AF\u2212 PVDF Core\u2212 sheath nanofiber mats with superhydrophobic properties","volume":"26","author":"Muthiah","year":"2010","journal-title":"Langmuir"},{"issue":"10","key":"10.1016\/j.ejps.2023.106631_bib0031","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1007\/s00417-021-05169-1","article-title":"Topical ketorolac as an adjunctive treatment with intravitreal bevacizumab in the management of diabetic macular edema: a double-masked placebo-controlled randomized clinical trial","volume":"259","author":"Nikkhah","year":"2021","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"2","key":"10.1016\/j.ejps.2023.106631_bib0032","doi-asserted-by":"crossref","first-page":"e10204","DOI":"10.1002\/btm2.10204","article-title":"Ultra-thin, high strength, antibiotic-eluting sutures for prevention of ophthalmic infection","volume":"6","author":"Parikh","year":"2021","journal-title":"Bioeng. Transl. Med."},{"issue":"12","key":"10.1016\/j.ejps.2023.106631_bib0033","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1185\/030079904X16759","article-title":"Efficacy of topical ketorolac tromethamine 0.4% for control of pain or discomfort associated with cataract surgery","volume":"20","author":"Price","year":"2004","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ejps.2023.106631_bib0034","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/476525","article-title":"Topical nonsteroidal anti-inflammatory drugs for macular edema","volume":"2013","author":"Russo","year":"2013","journal-title":"Mediators Inflamm"},{"issue":"10","key":"10.1016\/j.ejps.2023.106631_bib0035","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/bjophthalmol-2013-303417","article-title":"A randomised controlled trial of ranibizumab with and without ketorolac eyedrops for exudative age-related macular degeneration","volume":"97","author":"Russo","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ejps.2023.106631_bib0036","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0169-409X(95)00014-X","article-title":"Ocular inserts for topical delivery","volume":"16","author":"Saettone","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.ejps.2023.106631_bib0037","first-page":"1","article-title":"Preparation and characterization of gatifloxacin-loaded polyacrylonitrile nanofiber for the management of dry eye infection","volume":"18","author":"Sahu","year":"2022","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.ejps.2023.106631_bib0038","first-page":"5","article-title":"Ocular delivery of ketorolac tromethamine using microemulsion as a vehicle: design, evaluation, and transcorneal permeation","volume":"3","author":"Salimi","year":"2020","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.ejps.2023.106631_bib0039","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2174\/2211738508666200313140902","article-title":"Eudragit RL100 based moxifloxacin hydrochloride and ketorolac tromethamine combination nanoparticulate system for ocular drug delivery","volume":"8","author":"Salvi","year":"2020","journal-title":"Pharm. Nanotechnol."},{"key":"10.1016\/j.ejps.2023.106631_bib0040","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.msec.2016.11.076","article-title":"Controlled surface morphology and hydrophilicity of polycaprolactone toward human retinal pigment epithelium cells","volume":"73","author":"Shahmoradi","year":"2017","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"4","key":"10.1016\/j.ejps.2023.106631_bib0041","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3390\/nano9040532","article-title":"Electrospinning nanofibers for therapeutics delivery","volume":"9","author":"Shahriar","year":"2019","journal-title":"Nanomaterials"},{"issue":"1","key":"10.1016\/j.ejps.2023.106631_bib0042","first-page":"1","article-title":"Recent advancements in the development of heterocyclic anti-inflammatory agents","volume":"200","author":"Sharma","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejps.2023.106631_bib0043","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s40123-018-0130-1","article-title":"In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac\/Amfenac Ophthalmic Suspension 0.3% in Rabbits","volume":"7","author":"Sheppard","year":"2018","journal-title":"Ophthalmol. Ther."},{"issue":"4","key":"10.1016\/j.ejps.2023.106631_bib0044","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ophtha.2011.10.016","article-title":"Efficacy and safety of long-term corticosteroid eye drops after penetrating keratoplasty: a prospective, randomized, clinical trial","volume":"119","author":"Shimazaki","year":"2012","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ejps.2023.106631_bib0045","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/02713683.2018.1563196","article-title":"Development of nanofibrous ocular insert for retinal delivery of fluocinolone acetonide","volume":"44","author":"Singla","year":"2019","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejps.2023.106631_bib0046","series-title":"Biological Evaluation of Medical Devices\u2014Part 5: Tests for in Vitro Cytotoxicity","author":"Standard","year":"2009"},{"issue":"4","key":"10.1016\/j.ejps.2023.106631_bib0047","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3390\/life13040913","article-title":"Preparation and evaluation of nanofibrous and film-structured ciprofloxacin hydrochloride inserts for sustained ocular delivery: pharmacokinetic study in Rabbit's","volume":"13","author":"Taghe","year":"2023","journal-title":"Eye. Life."},{"issue":"2","key":"10.1016\/j.ejps.2023.106631_bib0048","first-page":"432","article-title":"Formulation of tolmetin ocuserts as carriers for ocular drug delivery system","volume":"16","author":"Tofighia","year":"2017","journal-title":"Iran. J. Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejps.2023.106631_bib0049","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/09273948.2016.1196713","article-title":"A focus on the epidemiology of uveitis","volume":"26","author":"Tsirouki","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"9","key":"10.1016\/j.ejps.2023.106631_bib0050","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jcrs.2007.05.015","article-title":"In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac","volume":"33","author":"Walters","year":"2007","journal-title":"J. Cataract. Refract. Surg."},{"key":"10.1016\/j.ejps.2023.106631_bib0051","article-title":"Development and optimization of vitamin E TPGS based PLGA nanoparticles for improved and safe ocular delivery of ketorolac","volume":"61","author":"Warsi","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"21","key":"10.1016\/j.ejps.2023.106631_bib0052","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1016\/j.polymer.2008.08.022","article-title":"Effect of fiber diameter on tensile properties of electrospun poly (\u025b-caprolactone)","volume":"49","author":"Wong","year":"2008","journal-title":"Polymer (Guildf)"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723002610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723002610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:29:41Z","timestamp":1777591781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098723002610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":52,"alternative-id":["S0928098723002610"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106631","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparation of polycaprolactone and polymethacrylate nanofibers for controlled ocular delivery of ketorolac tromethamine: Pharmacokinetic study in Rabbit's Eye","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106631","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106631"}}